BioLineRx (BLRX) Other Working Capital Changes (2015 - 2025)

BioLineRx's Other Working Capital Changes history runs 11 years deep, the most recent figure standing at $520000.0 for Q4 2025.

• In Q4 2025, Other Working Capital Changes rose 123.06% year-over-year to $520000.0; the TTM figure through Dec 2025 stood at $1.3 million (up 110.11% YoY), while the FY2025 annual figure was $1.3 million, up 110.11% from the prior year.
• Other Working Capital Changes was $520000.0 for Q4 2025 at BioLineRx, down from $790000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $13.5 million in Q4 2023 to a low of -$3.9 million in Q1 2024.
• Historically, Other Working Capital Changes has averaged $34200.0 across 5 years, with a median of -$178500.0 in 2021.
• The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes soared 5758.16% in 2023, then slumped 3147.93% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at $372000.0 in 2021, then slumped by 164.25% to -$239000.0 in 2022, then jumped by 5758.16% to $13.5 million in 2023, then sank by 116.68% to -$2.3 million in 2024, then soared by 123.06% to $520000.0 in 2025.
• The last three Other Working Capital Changes figures came in at $520000.0 (Q4 2025), $790000.0 (Q3 2025), and -$1.2 million (Q2 2025), per Business Quant data.